News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Bailey John E. (Jack) Jr.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/07/2023 |
4
| Bailey John E. (Jack) Jr. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 2,719 shares
@ $2.4537, valued at
$6.7k
|
|
| 05/12/2023 |
4
| Bailey John E. (Jack) Jr. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 160,000 shares
@ $0 |
|
| 01/05/2023 |
4
| Bailey John E. (Jack) Jr. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 80,700 shares
@ $0
Sold 32,019 shares
@ $5.8544, valued at
$187.5k
Sold 5,607 shares
@ $5.5756, valued at
$31.3k
Granted 161,300 options to buy
@ $5.73, valued at
$924.2k
|
|
| 01/05/2022 |
4
| Bailey John E. (Jack) Jr. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 46,000 shares
@ $0
Sold 34,125 shares
@ $10.4106, valued at
$355.3k
Granted 204,000 options to buy
@ $10.69, valued at
$2.2M
|
|
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/13/2020 |
4
| Bailey John E. (Jack) Jr. (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Bought 4,000 shares
@ $12.7637, valued at
$51.1k
Bought 4,000 shares
@ $12.83, valued at
$51.3k
|
|
| 06/12/2020 |
4
| Bailey John E. (Jack) Jr. (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $17.59, valued at
$351.8k
|
|
| 03/13/2020 |
4
| Bailey John E. (Jack) Jr. (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $12, valued at
$480k
|
|
| 03/13/2020 |
3
| Bailey John E. (Jack) Jr. (Director) has filed a Form 3 on G1 Therapeutics, Inc. |
|
|